| Net income | 180.6M |
| Income from discontinued operations, net of income taxes | |
| Depreciation | |
| Amortization | |
| Deferred income taxes | |
| Stock based compensation | 11.8M |
| Change in LIFO inventory reserve | |
| Amortization of unrecognized postretirement benefits | 32.27M |
| Loss on sale of assets | |
| Accounts and notes receivable | -67.94M |
| Inventories | -89.88M |
| Other current assets | |
| Accounts payable | 13.37M |
| Accrued liabilities | 19.01M |
| Other items | -13.73M |
| Net cash provided by (used in) continuing operations | 176.68M |
| Net cash provided by discontinued operations | |
| Net cash provided by (used in) operating activities | |
| Property, plant and equipment | |
| Acquisition of business, net of cash acquired | |
| Proceeds from the sale of assets | 331K |
| Net cash used in investing activities | |
| Payments on short-term debt | |
| Issuance of long-term debt | |
| Payments on long-term debt | -600K |
| Contributions by noncontrolling shareholder | |
| Acquisition of noncontrolling shareholder interest | |
| Payment of dividends to noncontrolling shareholders | -804K |
| Payment of dividends | -17.24M |
| Issuance of common shares and excess tax benefits on options | 3.71M |
| Net cash used in financing activities | |
| Effects of exchange rate changes on cash of continuing operations | -6.83M |
| Changes in cash and cash equivalents | -54.81M |
| Cash and cash equivalents at beginning of year | 505.16M |
| Cash and cash equivalents at end of period | 450.35M |